Bacteriophage Market

Bacteriophage Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The bacteriophage market size is expected to reach US$ 76.75 Million by 2032.

The bacteriophage market is expected grow at a CAGR of 5.8% from 2023 to 2032.

The bacteriophage market size was estimated to be US$ 43.68 Million in 2022.

The global bacteriophage market is being driven by several factors, including the increasing prevalence of antibiotic-resistant bacterial infections, growing demand for alternative therapies, and rising investment in research and development activities.

AmpliPhi Biosciences Corporation, Armata Pharmaceuticals, Inc., BiomX Ltd., Eligo Bioscience, EnBiotix, Inc., Fixed-Phage Limited, Intralytix, Inc., Locus Biosciences, Inc., Micreos BV, Phage International Inc., Phage Therapy Center, Pherecydes Pharma, TechnoPhage SA, The Eliava Institute, Vyriad, Inc. among others, are the major players in this market.

The Middle East and Africa bacteriophage market growth is being driven by the increasing prevalence of bacterial infections and the growing interest in bacteriophage therapy as a potential alternative to traditional antibiotics.

The gastroenterology is the largest segment in the bacteriophage market because the gut microbiome plays a crucial role in human health and disease.